Based on recent data, ORIC Pharmaceuticals, Inc. (ORIC) shows an Average True Range (ATR) of 0.87 and an Enterprise Value of 531.23M. Its average trading volume over the past 3 months is 1.95M, indicating liquidity. These fundamental metrics provide insight into ORIC's underlying financial health and market activity.
| ATR | 0.87 |
| Enterprise Value | 531.23M |
| Avg Vol (3 Months) | 1.95M |
| Avg Vol (10 Days) | 1.4M |
ORIC Pharmaceuticals, Inc. (ORIC) technical indicators as of April 20, 2026: the SMA 20 is 22.03%, SMA 50 at 32.36%, and SMA 200 at 29.02%. The RSI 14 value is 70.8, suggesting its current momentum. These technical analysis signals help assess ORIC's price trends and potential future movements.
| SMA 20 | 22.03% |
| SMA 50 | 32.36% |
| SMA 200 | 29.02% |
| RSI 14 | 70.8 |
ORIC Pharmaceuticals, Inc. (ORIC) stock performance overview as of April 20, 2026: The 52-week high is $14.93 (currently -9.58% below), and the 52-week low is $4.52 (currently 246.59% above). Over the past year, ORIC's performance is 15.74%, compared to the S&P 500's 25.03% change.
| 52-Week High | 14.93 |
| 52-Week High Chg | -9.58% |
| 52-Week Low | 4.52 |
| 52-Week Low Chg | +246.59% |
| S&P 500 52-Week Chg | 25.03% |
According to market data, ORIC Pharmaceuticals, Inc. (ORIC) stock's recent performance metrics show that over the last month, ORIC is 41.36%, with a Year-to-Date (YTD) performance of 42.05%. Over the past year, the stock has seen a 15.74% change. These figures summarize ORIC's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 10.98 | 13.04 | 14.25 | 14.5 | 14.93 | 14.25 |
| Low | 9.98 | 7.23 | 7.23 | 7.23 | 4.52 | 7.23 |
| Performance | +26.99% | +41.36% | -9.08% | +5.06% | +15.74% | +42.05% |
According to current financial data, ORIC stock's P/E (TTM) ratio is -7.29, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for ORIC, including P/S (N/A), P/B (2.46), and P/FCF (-9.63), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ORIC | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -7.29 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 2.46 | 7.34 | 0.65 | 4.99 |
| P/FCF (TTM) | -9.63 | 69.6 | -497.8 | 34.68 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep